drugset / Trial / NCT03593304

Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients

NCT03593304

RandomizedParallel-groupDouble-blindPrevention

Summary

This study will be conducted to evaluate the effect of vitamin B6 and vitamin B12 in reducing the incidence and severity and delaying the onset of Vincristine Induced neurotoxicity in Acute Lymphobalstic Leukemia (ALL) patient.

Timeline

Start
2018-03-29
Primary completion
2018-12-30
Completion
2019-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pyridoxine Unknown 50 mg Oral
Comparator methylcobalamin Small molecule 500 ug Intravenous